コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 strategy in the management of patients with Intraductal Papillary Mucinous Neoplasms.
2 2D) oncogene in the mouse pancreas to induce intraductal papillary mucinous neoplasms.
3 had pancreatic ductal adenocarcinoma, 17 had intraductal papillary mucinous neoplasms, 26 had symptom
4 rmed mainly for neuroendocrine tumors (35%), intraductal papillary mucinous neoplasms (33%), solid ps
5 premalignant (mucinous cystic neoplasm =16, intraductal papillary mucinous neoplasm = 5, neuroendocr
6 neuroendocrine tumors = 4), or 10 malignant (intraductal papillary mucinous neoplasm = 7, cystadenoca
7 etter for noninvasive compared with invasive intraductal papillary mucinous neoplasm (84.5% vs. 36%;
8 tic neoplasms (adenoma 28, borderline 7), 22 intraductal papillary mucinous neoplasms (adenoma 9, bor
9 ssessment of guidelines for the treatment of intraductal papillary mucinous neoplasm and cystic lesio
11 -term survival after resection of pancreatic intraductal papillary mucinous neoplasm and to correlate
12 ted neoplasms were identified in 85 HRIs (82 intraductal papillary mucinous neoplasms and 3 pancreati
13 n had high-grade dysplasia in less than 3 cm intraductal papillary mucinous neoplasms and in multiple
14 onitored clinically, mucinous cysts, such as intraductal papillary mucinous neoplasms and mucinous cy
15 guidelines for mucinous cystic neoplasm and intraductal papillary mucinous neoplasm are superior to
19 ctively reviewed and classified 113 resected intraductal papillary mucinous neoplasms as invasive car
20 ts (72%) and in small (</=30 mm) branch-duct intraductal papillary mucinous neoplasm (BD IPMN; 67%),
21 pancreatic cysts, especially for branch duct intraductal papillary mucinous neoplasms (BD-IPMNs), rem
22 s known about the development of branch duct intraductal papillary mucinous neoplasms (BD-IPMNs).
24 l benign, whereas mucinous cystic neoplasms, intraductal papillary mucinous neoplasm, cystic neuroend
25 ing cystic tumors (mucinous cystic neoplasms+intraductal papillary mucinous neoplasms) from benign cy
26 pancreatic surgery, only one patient with an intraductal papillary mucinous neoplasm had high-grade d
27 l consensus guidelines for the management of intraductal papillary mucinous neoplasm (IPMN) and mucin
28 uidelines for management of branch duct (BD) intraductal papillary mucinous neoplasm (IPMN) espouse s
29 ted with main pancreatic duct (MPD)-involved intraductal papillary mucinous neoplasm (IPMN) has been
30 to malignancy of pancreatic branch-duct (BD) intraductal papillary mucinous neoplasm (IPMN) is infreq
31 and mucin staining were similar to those of intraductal papillary mucinous neoplasm (IPMN) of the pa
32 reatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasm (IPMN) precursor
35 arcinoma (PDAC) and its preneoplastic lesion intraductal papillary mucinous neoplasm (IPMN), to find
37 a large single-center population of resected intraductal papillary mucinous neoplasms (IPMN) of the p
38 l consensus guidelines for the management of intraductal papillary mucinous neoplasms (IPMN) recommen
39 ogression following resection for pancreatic intraductal papillary mucinous neoplasms (IPMN) using ta
40 (1.8%): 12 pseudocysts, 2 cysts/remnants, 4 intraductal papillary mucinous neoplasms (IPMN), 2 adeno
42 between SCA and premalignant mucinous cysts (intraductal papillary mucinous neoplasm [IPMN], mucinous
43 GNAS-activating mutations are reported in intraductal papillary mucinous neoplasms (IPMNs) and in
44 lly-detected cystic PDAC precursors known as intraductal papillary mucinous neoplasms (IPMNs) and pre
46 nsus Guidelines, the diagnostic criterion of intraductal papillary mucinous neoplasms (IPMNs) involvi
47 ad use and advances in radiographic imaging, Intraductal Papillary Mucinous Neoplasms (IPMNs) of the
48 inoma may be encountered in association with intraductal papillary mucinous neoplasms (IPMNs) of the
52 stic cyst types: serous cystadenomas (SCAs), intraductal papillary mucinous neoplasms (IPMNs), mucino
56 ients with mucinous cystic neoplasms (n=17), intraductal papillary mucinous neoplasms (n=15), serous
57 l features of invasive carcinomas arising in intraductal papillary mucinous neoplasms of the pancreas
59 (1.9%) had high-risk lesions (ie, high-grade intraductal papillary mucinous neoplasms or grade 3 panc
62 plasms-related tumors (4/58, 6.9%) than non- intraductal papillary mucinous neoplasms PDAC (5/385, 1.
66 les; we found dMMR in a larger proportion of intraductal papillary mucinous neoplasms-related tumors
68 e, that Tif1gamma and Smad4 both regulate an intraductal papillary mucinous neoplasm-to-PDAC sequence
69 , including 3 node-negative R0 microinvasive intraductal papillary mucinous neoplasms (without recurr
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。